Related Experiment Videos
Hydroxylation and oxidation of nalidixic acid in the turtle Pseudemys scripta elegans
T B Vree1, J B Vree, A M Baars
1Department of Clinical Pharmacy, Sint Radboud Hospital, University of Nijmegen, The Netherlands.
The Veterinary Quarterly
|January 1, 1988
Summary
The turtle Pseudemys scripta elegans metabolizes nalidixic acid into 7-hydroxynalidixic acid and 7-carboxynalidixic acid. Unlike humans, turtles do not form glucuronides of these nalidixic acid metabolites.
Area of Science:
- Pharmacokinetics and Metabolism
- Comparative Toxicology
- Herpetology
Background:
- Nalidixic acid is a first-generation fluoroquinolone antibiotic.
- Understanding drug metabolism in non-human species is crucial for ecotoxicology and comparative pharmacology.
- Pseudemys scripta elegans (red-eared slider turtle) is a common model organism.
Purpose of the Study:
- To investigate the metabolic pathways of nalidixic acid in the turtle Pseudemys scripta elegans.
- To determine the elimination half-life of nalidixic acid in this species.
- To compare the metabolism of nalidixic acid in turtles with that observed in humans.
Main Methods:
- In vivo administration of nalidixic acid to Pseudemys scripta elegans.
- Analysis of plasma and excreta for drug metabolites using chromatographic techniques.
- Pharmacokinetic analysis to determine elimination half-life.
Main Results:
- Nalidixic acid is hydroxylated to 7-hydroxynalidixic acid.
- 7-hydroxynalidixic acid is further oxidized to 7-carboxynalidixic acid.
- The elimination half-life of nalidixic acid in turtles is approximately 30 hours.
- No glucuronide conjugates of nalidixic acid or its metabolites were detected in turtles.
Conclusions:
- Pseudemys scripta elegans possesses distinct metabolic pathways for nalidixic acid compared to humans.
- The turtle's inability to form glucuronides of nalidixic acid and its metabolites suggests species-specific conjugation enzyme activity.
- The determined half-life provides valuable data for potential ecotoxicological risk assessments involving fluoroquinolones in aquatic environments.